Want to join the conversation?
$BIIB's 4Q15 product sales grew 6% YoverY to $2.43Bil, up from $2.28Bil a year earlier. Tecfidera's revenue for the quarter was $993MM, as the sales in the US increased slightly to $785MM. Revenue for Tysabri fell to $480.7MM, while Avonex fell 13% YoverY to $637.2MM. Meanwhile, quarterly sales of Plegridy doubled to $102MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)